Guidelines - ESMO
ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW) ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) COVID-19 and Cancer: Registries, Studies and Surveys. ESMO Designated Centres of Integrated Oncology and Palliative Care. Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris.
Guidelines | ESMO
ESMO Guidance for Reporting Oncology real-World Evidence (ESMO-GROW) ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) COVID-19 and Cancer: Registries, Studies and Surveys. ESMO Designated Centres of Integrated Oncology and Palliative Care. Palliative and Supportive Care Sessions at ESMO Congress 2022 Paris.
Clinical Practice Guidelines on Breast Cancer - ESMO
Oct 25, 2022 · The ESMO Clinical Practice Guidelines on Early and Metastatic Breast Cancer cover information on screening, diagnosis, pathology and molecular biology, staging and risk assessment, disease management, monitoring and follow-up, palliative care and the patient perspective. There are also specific guidelines focusing on risk reduction and ...
ESMO Cancer Guidelines available on mobile devices
The ESMO Interactive Guidelines App is compatible with Android and iOS devices and includes content from the ESMO Pocket Guidelines. These quick reference booklets provide the most important content of the full ESMO Clinical Practice Guidelines on the management of various cancers. Key content includes diagnostic criteria, staging of disease ...
Clinical Practice Guidelines on Lung Cancer - ESMO
Jul 1, 2017 · ESMO has Clinical Practice Guidelines on the following Lung and Chest Tumours: Early and locally advanced non-small-cell lung cancer, Metastatic non-small-cell lung cancer, Thymic epithelial tumours, Malignant pleural mesothelioma, Small-cell lung cancer. They include information on incidence, diagnosis, staging and risk assessment, treatment ...
ESMO
16 hours ago · ESMO Calls for Concerted Action to Prevent Burnout and Foster Well-Being within the Oncology Workforce. The European Society for Medical Oncology (ESMO) is calling on all actors of the oncology community to commit to improving the well-being of the cancer workforce and join in 11 actions outlined in a paper published today in ESMO Open.
Clinical Practice Guidelines on Haematological Malignancies - ESMO
Jun 19, 2018 · Latest enhanced and revised set of guidelines. ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Acute lymphoblastic leukaemia, Acute myeloblastic leukaemia in adult patients, Chronic lymphocytic leukaemia, Chronic myeloid leukaemia, Diffuse large B cell lymphoma, Elderly patients with malignant lymphoma, Extranodal diffuse large B-cell lymphoma and primary ...
eUpdate – Hepatocellular Carcinoma Treatment …
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines. Published: 05 March 2021. Authors: ESMO Guidelines Committee. Note: This eUpdate replaces all previous eUpdates published for these guidelines. The following ESMO Clinical Practice Guideline has been recently updated with new ...
Gastrointestinal Cancers | ESMO
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2023;34 (11):987-1002. Conroy T, Pfieiffer P, Vilgrain V, et al., on behalf of the ESMO Guidelines Committee. The guideline covers diagnosis, staging, risk assessment, treatment, disease monitoring and follow-up.
Management. Non-severe diarrhoea. Treatment with antidiarrhoeals, fluid and electrolyte supplementation, if required, and ICPis can be continued. Persistent grade 2 / severe grade 3–4 / grade 1-2 with alarm symptoms. ICPi discontinuation and initiation of systemic corticosteroids (1 to 2 mg/kg IV daily) Response to IV corticosteroids.